Yann De Rycke

Feb 14, 2024 | onlinelibrary.wiley.com | Stéphane Auvin |CRMR épilepsies rares |Yann De Rycke |Sylvie Guillo

CONFLICT OF INTEREST STATEMENT S.A. has served as a consultant for or received honoraria for lectures from Angelini Pharma, Biocodex, BioMarin, Eisai, GW Pharma, Neuraxpharm, Nutricia, UCB Pharma, Xenon, and Zogenix. He has been an investigator for clinical trials for Eisai, UCB Pharma, Xenon, and Zogenix.